Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessStocks

Hold Aurobindo Pharma; target of Rs 710: Sharekhan

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated August 08, 2019.

August 12, 2019 / 05:11 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan's research report on Aurobindo Pharma

Q1 numbers were strong; new products, better product mix and operational efficiencies led to robust profitability. Gross debt reduced by ~ Rs 1,084 crore to Rs. 5883.2 crore; net debt fell by Rs. 915 crore to Rs. 4,094 crore. Regulatory hurdles at various plants would weigh on stock until successful resolution.

Outlook

We maintain a Hold rating with an unchanged PT of Rs. 710. We expect company to report sales and profit CAGRs of 29% and 22%,
respectively, in the next two years.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Aug 12, 2019 05:11 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347